Intestinal functions in the critically ill patients;Intestinale funktionen beim kritisch kranken patienten

Chirurgische Gastroenterologie Interdisziplinar

Volumn 16, Issue SUPPL. 1, 2000, Pages 13-22

  Stein, J ^a   Bolder, U ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b NONE

Author keywords

Bacterial translocation; Critically ill patients; Instestinal barrier function; MODS; SIRS

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOKINE; NITRIC OXIDE; OXYGEN RADICAL;

BACTEREMIA; BACTERIAL TRANSLOCATION; CRITICAL ILLNESS; ENDOTOXEMIA; FUNGEMIA; HUMAN; INTESTINE FUNCTION; INTESTINE ISCHEMIA; INTESTINE LYMPHATIC TISSUE; LIVER FUNCTION; MALABSORPTION; MULTIPLE ORGAN FAILURE; PERMEABILITY BARRIER; REVIEW; SEPSIS; STRESS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 12944249321     PISSN: 01779990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Baron P, Traber LD, Traber DL, Nguyen T, Hollyoak M, Heggers JP, Herndon DN: Gut failure and translocation following burn and sepsis. J Surg Res 1994;57:197-204.
2. Carrico CJ, Meakins JL, Marshall JC, Ry D, Maier RV: Multiple organ failure syndrome. Arch Surg 1986;121:196-208.
3. Fraenkel A: Ueber peritoneale Infektion. Wien Klin Wochenschr 1891;121:265-285.
4. Flexner S: Peritonitis cused by invasion of micrococcus Lanceolatus from the intestine. Johns Hopkins Hosp Bull 1895;6:64-67.
5. Hornemann F: Beitrag zur Frage ueber die Bakteriendurchlässigkeit der Schleimhaut des Magendarmkanals. Z Hyg 1911;64:39-67.
6. Mandl F: Beitrag zur Frage der kryptogenetischen Peritonitis. Dtsch Z Chir 1923;182:289-307.
7. Arnold L: Passage of bacteria through the intact intestinal mucosa. Proc Exp Biol Med 1928;25: 247-248.
8. Arnold L: Alterations in the endogenous enteric bacterial flora and microbic permeability of the intestinal wall in relation to the nutritional and meterological changes. J Hyg 1930;29:82-116.
9. Schweinberg FB, Seligman AM, Fine J: Transmural migration of intestinal bacteria. N Engl J Med 1950;242:752-755.
10. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-1655.
11. Lundgreen O, Haglund U: The pathophysiology of the intestinal countercurrent exchanger. Life Sci 1978;23:1411-1422.
12. Stein J, Kottra G: Intestinale Schlußleisten. I. Aufbau und molekulare Regulation. Z Gastroenterol; 1997;35:205-220.
13. Spencer J, Finn T, Isaacson PG: Human Peyer's patches: An immunohistochemical study. Gut 1986;27:405-410.
14. Pabst R: Der Verdauungstrakt als Immunorgan. Med Klin Prax 1983;78:14-20.
15. Herndon DN, Zeigler ST: Bacterial translocation after thermal injury. Crit Care Med 1993;21:S50-54.
16. Hyslop PA, Hinshaw DP, Halsey WA: Mechanism of oxidant-mediated cell injury: The glycolytic and mitochondrial pathways of ADP phosphorylation are majorintracellular targets inactivated by hydrogen peroxyde. J Biol Chem 1988;253:1665-1675.
17. Owen RL, Jones AL: Epithelial cell specialization within human Peyer's patches: An ultrastructural study of intestinal lymphoid follicles. Gastroenterology 1974;66:189-203.
18. Croitoru K, Bienenstock J: Mucosal immunity; in Metcalfe DD, Sampson HA, Simon RA (eds): Food Allergy: Adverse Reactions to Foods and Food Additives. Oxford, Blackwell, 1991.
19. Nieuwenhuijzen GAP, Deitch EA, Goris RJA: Infection, the gut and the development of the multiple organ dysfunction syndrome. Eur J Surg 1996;162:259-273.
20. Fukushima R, Gianotti L, Alexander JW: The primary site of bacterial translocation. Arch Surg 1994;129:53-58.
21. Dyer J, Hosie KB, Shirazi-Beechey SP: Nutrient regualtion of human intestinal sugar transporters. Gut 1997;41:56-59.
22. Inoue S, Wirman JA, Alexander JW: Candida albicans translocation across the gut mucosa following burn injury. J Surg Res 1988;44:479-492.
23. Fink MP: Gastrointestinal mucosal injury in experimental models of shock, trauma, and sepsis. Crit Care Med 1991;19:627-641.
24. Seifert J: Resorption von Makromolekülen aus dem Gastrointestinaltrakt; in Caspary WF (Hrsg): Handbuch der Inneren Medizin, Band 3/3 a, Dünndarm. Berlin, Springer, 1983, pp 395-418.
25. Morales J, Kibsey P, Thomas PD, Poznansky MJ, Hamilton SM: The effects of ischemia and ischemia-reperfusion on bacterial translocation, lipid peroxidation, and gut histology: Studies on hemorrhagic shock in pigs. J Trauma 1992;3:221-226.
26. Vaughan WG, Horton JW, Walker PB: Allopurinol prevents intestinal permeability changes after ischemia-reperfusion injury. J Pediatr Surg 1992; 27:968-972.
27. Wolfram G: Omega-3-Fettsäuren - ihr Stoffwechsel und ihre Wirkungen auf vaskuläres System, Fettstoffwechsel und Immunsystem. Akt Ernährungsmed 1995;20:173-179.
28. Zhi-Yong S, Dong YL, Wang XH: Bacterial translocation and multiple system organ failure in bowel ischemia and reperfusion. J Trauma 1992;32:148-153.
29. Park PO, Haglund U, Bulkley GV, et al: The sequence of development of intestinal tissue injury following strangulation ischemia and reperfusion. Surgery 1990;107:574-580.
30. Bulkley GB, Kvietys PR, Parks DA: Relationship of blood flow and oxygen consumption to ischemic injury in the canine small intestine. Gastroenterology 1985;89:852-857.
31. Granger DN: Role of xanthine oxidase and granulocytes in ischenia-reperfusion injury. Am J Physiol 1988;255:H1269-1275.
32. BBe monolayers. Am J Physiol 1996;270:G1010-1021.
33. Teppermann BL, Brown JF, Korolkiewicz R, Whittle BJ: Nitric oxide synthetase activity, viability and cyclic GMP levels in rat colonic epithelial cells: Effects of endotoxin challange. J Pharmacol Exp Ther 1994;271:1477-1482.
34. Unno N, Menconi MJ, Smith M, Fink MP: Nitric oxide mediates interferon-y-induced hyperpermeability in cultured human intestinal epithelial monolayers. Crit Care Med 1995;23:1170-1176.
35. BBe intestinal epithelial monolayers. Am J Physiol 1995;268:G361-373.
36. Hutcheson IR, Whittle BJ, Boughton-Smith NK: Role of nitric oxide in maintaining vascular integrity in endotoxin-induced intestinal damage in the rat. Br J Pharmacol 1990;101:815-820.
37. Tremel H, Kienle B, Weilermann LS, Stehle P, Fürst P: Glutamine dipeptide - supplemented parenteral nutrition maintains intestinal function in the critically ill. Gastroenterology 1994;107: 1595-1601.
38. Murphy MS, Walker WA: Antigen absorption; in Metcalfe DD, Sampson HA, Simon RA (eds): Food Allergy: Adverse Reactions to Foods and Food Additives. Oxford, Blackwell, 1991.
39. Reynolds JV, Murchan P, Leonard N, Gough DB: High-dose interleukin 2 promotes bacterial translocation from the gut. Br J Cancer Suppl 1995;72:634.
40. Riehl TE, Stenson WF: Mechanisms of transit of lipid mediators of inflammation and bacterial peptides across intestinal epithelia. Am J Physiol 1994;267:G687-695.
41. Dignass A, Milovic V: Wachstumsfaktoren und Wachstumsregulation im Intestinaltrakt; in Caspary WF, Stein J (eds): Darmkrankheiten. Berlin, Springer, 1999, pp 63-70.
42. Austgen TR, Chen MK, Dudrick PS, Copeland EM, Souba WW: Cytokine regulation of intestinal glutamine utilization. Am J Surg 1992; 163:174-180.
43. Gianotti L, Alexander JW, Gennari R, Pyles T: Oral glutamine decreases bacterial translocation and improves survival in experimental gut-origin sepsis. JPEN J Parenter Enteral Nutr 1995;19:69.
44. O'Riordain MG, Fearon KC, Ross JA, Rogers P, Falconer JS, Bartolo DC, Garden OJ, Carter DC: Glutamine-supplemented total parenteral nutrition enhances T-lymphocyte response in surgical patients undergoing colorectal resection. Ann Surg 1994;220:212-221.
45. Scheppach W: Wirkung von Ballaststoffen, kurzkettigen Fettsäuren und Glutamin auf die Funktion des Dünn- und Dickdarms; in Caspary WF, Stein J: Darmkrankheiten. Berlin, Springer 1999, pp 685-689.
46. Gianotti L, Alexander JW, Fukushima R, Pyles T: Reduction of bacterial translocation with oral fibroblast growth factor and sucralfate. Am J Surg 1993;165:195-200.
47. +-dependent glutamine transport across the brush border membrane of monolayers of human intestinal Caco-2 cells. Ann Surg 1992; 215:536-545.
48. Inoue Y, Espat J, Frohapple DJ, Epstein H, Copeland W, Souba W: Effect of parenteral nutrition on amino acid and glucose transport in the human small intestine. Ann Surg 1993;217:604-614.
49. O'Dwyer ST, Michie HR, Ziegler TR, Revhaug A, Smith RJ, Wilmore DW: A single dose of endotoxin increases intestinal permeability in healthy humans. Arch Surg 1988;123:1459-1464.
50. Roumen RM, Hendriks T, Wevers RA, Goris JA: Intestinal permeability after severe trauma and hemorrhagic shock is increased without relation to septic complications. Arch Surg 1993;128:453-457.
51. Brathwaite CE, Ross SE, Nagele R, Mure AJ, O'Malley KF, Garcia-Perez FA: Bacterial translocation occurs in humans after traumatic injury: Evidence using immunifluorescence. J Trauma 1993;34:586-590.
52. Stein J, Ries J, Schröder O, Zeuzem S, Caspary WF: Methodischer Zugang zur Messung der Permeabilität des Dünndarmes; in Caspary WF, Kist P, Zeitz M (Hrsg): Ökosystem Darm VI. Berlin, Springer, 1994, pp 72-84.
53. Illig KA, Ryan CK, Hardy DJ, Rhodes J, Locke W, Sax HC: Total parenteral nutrition-induced changes in gut mucosal function: Atrophy alone is not the issue. Surgery 1992;112:631-637.
54. Sedman PC, Macfie J, Sagar P, Mitchell CJ, May J, Mancey-Jones B, Johnstone D: The prevalence of gut translocation in humans. Gastroenterology 1994;107:643-649.
55. Marshall JC, Christou NV, Meakins JL: The gastrointestinal tract - the undrained abscess of multiple organ failure. Ann Surg 1993;218:111-119.
56. Runyon BA, Borzio M, Young S, Squier SU, Guarner C, Runyon MA: Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis. Hepatology 1995;21:1719-1724.
57. Kerver AJH, Rommes JH, Mevissen-Verhage EAE, Hulstaert-PF, Vos A, Verhoef J, Wittebol P: Prevention of critically ill patients: A prospective randomized study. Crit Care Med 1988;16:1087-1093.
58. Bolder U, Ton-Nu HT, Schteingart CD, Frick E, Hofmann AF: Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion. Gastroenterology 1997; 112:214-225.
59. Moseley RH, Wang W, Takeda H, Lown K, Shick L, Ananthanarayanan M, Suhy F: Effect of endotoxin on bile acid transport in rat liver: A potential for sepsis associated cholestasis. Am J Physiol 1996;271:G137-146.
60. Pacitti AJ, Inoue Y, Souba WW: Tumor necrosis factor stimulates amino acid transport in plasma membrane vesicles from rat liver. J Clin Invest 1993;91:474-483.
61. Huang KF, Chung DH, Herndon DN: Insulinlike growth factor 1 (IGF-1) reduces gut atrophy and bacterial translocation after severe burn injury. Arch Surg 1993;128:47-53.
62. Kudsk KA, Croce MA, Fabian TC, Minard G, Tolley EA, Poret HA, Kuhl MR, Brown RO: Enteral versus parenteral feeding - effects on septic morbidity after blunt and penetrating abdominal trauma. Ann Surg 1992;215:503-603.
63. Sax HC, Illig KA, Ryan CK, Hardy DJ: Low-dose enteral feeding is beneficial during total parenteral nutrition. Am J Surg 1996;17:587-590.
64. ASPEN Board of directors: Nutrition support for adults with specific diseases and conditions. JPEN 1993;17:12SA-26SA.
65. Parks RW, Clements WDB, Smye MG, Pope C, Rowlands BJ, Diamond T: Intestinal barrier dysfunction in clinical and experimental obstructive jaundice and its reversal by internal biliary drainage. Br J Surg 1996;83:1345-1349.
66. Prod'hom G, Leuenberger P, Koerfer J, Blum A, Chiolero R, Schaller MD, Perret C, Spinnler O, Blondel J, Siegrist H: Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial. Ann Intern Med 1994;120:653-662.
67. van Staden AM, van Rensburg CE, Anderson R: Vitamin E protects mononuclear leucocyte DNA against damage mediated by phagocyte-derived oxidants. Mutat Res 1993;288:257-262.